Ignite Creation Date:
2025-12-25 @ 1:09 AM
Ignite Modification Date:
2025-12-25 @ 11:20 PM
Study NCT ID:
NCT03448393
Status:
COMPLETED
Last Update Posted:
2025-06-04
First Post:
2018-02-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-26
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-13
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-27
First Submit QC Date:
None
Study First Post Date:
2018-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-04-25
Results First Submit QC Date:
None
Results First Post Date:
2025-06-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-15
Last Update Post Date:
2025-06-04
Last Update Post Date Type:
ACTUAL